ML

Michael R. Leadbetter

TH Theravance: 35 patents #14 of 116Top 15%
AR Ardelyx: 22 patents #4 of 28Top 15%
AM Advanced Medicine: 3 patents #4 of 34Top 15%
ZL Zeneca Limited: 2 patents #278 of 867Top 35%
IA Ici Americas: 2 patents #84 of 250Top 35%
TI Theravance Biopharma R&D Ip: 2 patents #80 of 116Top 70%
IC ICI: 1 patents #1,088 of 2,189Top 50%
📍 Fremont, CA: #144 of 9,298 inventorsTop 2%
🗺 California: #4,640 of 386,348 inventorsTop 2%
Overall (All Time): #30,885 of 4,157,543Top 1%
68
Patents All Time

Issued Patents All Time

Showing 1–25 of 68 patents

Patent #TitleCo-InventorsDate
12084472 Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists Jason G. Lewis, Jeremy Caldwell, Dean R. Dragoli, Noah Bell, Jeffrey W. Jacobs +4 more 2024-09-10
12016856 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Dominique Charmot, Marc Navre, Christopher Carreras, Noah Bell, Jeffrey W. Jacobs 2024-06-25
11858959 Glycyrrhetinic acid derivatives for use in treating hyperkalemia Dean R. Dragoli, Gary W. Luehr, Tao Chen, Jason G. Lewis 2024-01-02
11768319 Glycyrrhetinic acid derivatives for treating hyperkalemia Gary W. Luehr, Dean R. Dragoli, Tao Chen, Jason G. Lewis 2023-09-26
11318129 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Dominique Charmot, Marc Navre, Christopher Carreras, Noah Bell, Jeffrey W. Jacobs 2022-05-03
10968246 Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists Jason G. Lewis, Jeremy Caldwell, Dean R. Dragoli, Noah Bell, Jeffrey W. Jacobs +4 more 2021-04-06
10543207 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Dominique Charmot, Marc Navre, Christopher Carreras, Noah Bell, Jeffrey W. Jacobs 2020-01-28
10392413 Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists Jason G. Lewis, Jeremy Caldwell, Dean R. Dragoli, Noah Bell, Jeffrey W. Jacobs +4 more 2019-08-27
10385024 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Noah Bell, Christopher Carreras, Dominique Charmot, Tao Chen, Jeffrey W. Jacobs +1 more 2019-08-20
10376481 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Noah Bell, Christopher Carreras, Jason G. Lewis, Jeffrey W. Jacobs, Irina DOTSENKO +4 more 2019-08-13
9408840 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder Noah Bell, Christopher Carreras, Dominique Charmot, Jeffrey W. Jacobs, Marc Navre 2016-08-09
9301951 Compounds and methods for inhibiting phosphate transport Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Noah Bell, Han-Ting Chang +5 more 2016-04-05
9289430 Compounds and methods for inhibiting phosphate transport Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Noah Bell, Han-Ting Chang +5 more 2016-03-22
9289429 Compounds and methods for inhibiting phosphate transport Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Noah Bell, Han-Ting Chang +5 more 2016-03-22
9278102 Compounds and methods for inhibiting phosphate transport Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Noah Bell, Han-Ting Chang +5 more 2016-03-08
9006281 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Noah Bell, Christopher Carreras, Dominique Charmot, Jeffrey W. Jacobs, Marc Navre 2015-04-14
8969377 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Noah Bell, Christopher Carreras, Dominique Charmot, Jeffrey W. Jacobs, Marc Navre 2015-03-03
8969370 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Sean G. Trapp, Daniel D. Long, Pierre-Jean Colson, Miroslav Rapta, Ying Yu 2015-03-03
8952031 Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Sean G. Trapp, Daniel D. Long, Lan Jiang, Sabine Axt 2015-02-10
8916569 Compounds and methods for inhibiting phosphate transport Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Noah Bell, Han-Ting Chang +5 more 2014-12-23
8859506 Glycopeptide phosphonate derivatives 2014-10-14
8815910 Compounds and methods for inhibiting phosphate transport Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Noah Bell, Han-Ting Chang +5 more 2014-08-26
8815908 Compounds and methods for inhibiting phosphate transport Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Noah Bell, Han-Ting Chang +5 more 2014-08-26
8809339 Compounds and methods for inhibiting phosphate transport Jason G. Lewis, Jeffrey W. Jacobs, Nicholas Reich, Noah Bell, Han-Ting Chang +5 more 2014-08-19
8703791 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Sean G. Trapp, Daniel D. Long, John R. Jacobsen, Priscilla Van Dyke 2014-04-22